The seventh cholera pandemic, which began in 1960 to 1961 and continues today, was caused by the El Tor biotype of Vibrio cholerae O group 1. The classical biotype, the principal cause of cholera before the current pandemic, is now rarely found. Historically, the classical and El Tor biotypes were differentiated by the ability of the El Tor biotype to hemolyze erythrocytes. However, early in the seventh cholera pandemic, a number of authors reported nonhemolytic V. cholerae O1 isolates which otherwise resembled the El Tor biotype (3, 5, 7, 9, 12) . The two biotypes are now generally distinguished by other characteristics. These include the Voges-Proskauer test, agglutination of chicken erythrocytes (10) , and resistance to polymyxin B (13) and to Mukerjee phage IV (14) . Gallut reported that by 1972 almost all El Tor isolates worldwide were nonhemolytic (11) .
Subsequently, interest in the hemolytic activity of El Tor strains apparently waned, and the prevalence of hemolytic activity for strains isolated since 1972 is unclear.
In 1973 and 1978, V. cholerae O1 infections caused by markedly hemolytic El Tor vibrios occurred in Texas (17) and Louisiana (4) . When hemolytic V. cholerae strains were isolated after their supposed disappearance, we suspected that the 1973 and 1978 cases may have resulted from persistence of the organisms in the United States rather than from separate importations, and we decided to reexamine the phenomenon of hemolysis. We attempted to reconstruct the changes which have occurred during the past 20 years by using methods suggested by several authors to examine strains collected worldwide during the current pandemic.
MATERIALS AND METHODS
A total of 87 V. cholerae O1 strains were examined for hemolytic activity using four methods. These strains were collected between 1960 and 1979 and were resistant to polymyxin B and Mukerjee phage IV and toxigenic by the Y-1 adrenal cell assay (6) . They included strains from the following areas (number of strains is shown in parentheses): Europe (2), Asia (28), Africa (8) , Oceania (3) , the Middle East (7), a case of cholera in Texas in 1973 (1), and strains of both human (11) and environmental (27) origins isolated in Louisiana in 1978 (2, 4), Since strains were obtained from several laboratories, storage methods varied, but most strains had been kept lyophilized since isolation.
Method 1. Feeley and Pittman (8) recommended growing cultures in heart infusion broth (HIB) (Difco; pH 7.4) at 35°C for 24 h, centrifuging, and titrating the supernatant. Serial twofold dilutions were made in phosphate-buffered saline (pH 6.8 to 7.0), and 0.5 ml of a 1% suspension of sheep erythrocytes was added to 0.5 ml of each dilution of supernatant. After they were incubated for 2 h in a 37°C water bath, the suspensions were kept overnight at 4°C and examined for hemolysis. Titers were recorded as the highest dilution at VOL. 13, 1981 which complete hemolysis occurred. Supernatants heated to 56°C for 30 min were also included to assure that any hemolysis reflected the presence of a heatlabile hemolysin.
Method 2. Barua and Mukherji (3) suggested that HIB with 1% glycerol was superior to plain HIB. We used the same methods and conditions described above, except we added 1% glycerol to the same lot of heart infusion broth (HIBG). This differs from the method described by Sakazaki et al. (15) erythrocyte plate. Higher titers were generally measured with the HIBG method than with the HIB method; of the 57 strains shown to be hemolytic with any method, higher titers were measured for 35 (62.5%) with the HIBG method, whereas higher titers were measured for only 2 (3.6%) with the HIB method (P < 0.001, McNemar test). Hemolytic strains usually had hemolysin titers of 16 or higher in measurements with both the HIBG (87.7%) and HIB (92.9%) methods (Table  2) .
To examine the changes that occurred in he- (7, 9) . In 1970, Sen and Shrivastava found hemolytic activity to be a stable property and argued that all nonhemolytic V. cholerae O1 were of the classical biotype (16) . In 1971, Sakazaki et al. reported that 99% of the strains resistant to phage IV and polymyxin B that they tested had some hemolytic activity (15) (4) .
The fact that the Texas strain and all of the Louisiana strains (from patients, sewage, and the environment), which were of the same phage type (4) and presumably at one time came from a common source, had hemolysin titers of -16 suggests that, at least for these strains, the level of hemolysis measured may be a stable property under natural conditions. Although it is certainly possible that some of our older Eastern Hemisphere test strains lost their hemolytic ability during storage, the oldest (1960 to 1962) isolates were the most hemolytic, suggesting that storage probably had little effect on the results.
We conclude that when a V. cholerae O1 isolate is found to have hemolytic activity that is unusual for the area (currently, this would be hemolytic in the Eastern Hemisphere and nonhemolytic in the Western Hemisphere), this characteristic can be used in epidemiological studies to trace the spread of the strain. Although the HIBG method would be preferable because it can be used to measure titers, for practical purposes a standard blood plate can be used. Anaerobic incubation of the blood plate, as suggested by de Moor (5) , is recommended to avoid hemodigestion by metabolic end products which may be confused with true hemolysis caused by the heat-labile hemolysin. Ideally, the identity of representative strains should later be confirmed biochemically, serologically, and by phage typing.
